Trials / Completed
CompletedNCT04720430
Blood Sample Collection for Experimental Blood Test to Track Liver Cancer
Circulating MicroRNA Levels as a Predictor of Successful Bridging or Down-Staging Loco-Regional Therapy (LRT) to Liver Transplantation for Patients With Hepatocellular Carcinoma (HCC)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 7 (actual)
- Sponsor
- Thomas Jefferson University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
This study investigates if an experimental blood test can help predict how well cancer will remain under control with treatment. Ther experimental blood test involves measuring mircoRNAs. MicroRNAs are small molecules which help regulate how genes are expressed. This information may help researchers guide treatment for other patients in the future.
Conditions
Timeline
- Start date
- 2019-12-03
- Primary completion
- 2023-02-15
- Completion
- 2023-11-09
- First posted
- 2021-01-22
- Last updated
- 2025-04-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04720430. Inclusion in this directory is not an endorsement.